KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Raw Materials (2010 - 2012)

West Pharmaceutical Services recorded quarterly Raw Materials of $68.6 million in Q2 2012, up 5.38% quarter-over-quarter from $65.1 million in Q4 2011, and up 4.41% year-over-year from $65.7 million in Q3 2011.

West Pharmaceutical Services' Raw Materials history runs 3 years deep, the most recent figure standing at $68.6 million for Q2 2012.

  • In Q2 2012, Raw Materials rose 4.41% year-over-year to $68.6 million; the TTM figure through Jun 2012 stood at $68.6 million (up 4.41% YoY), while the FY2011 annual figure was $65.1 million, up 7.6% from the prior year.
  • Raw Materials came in at $68.6 million for Q2 2012 at West Pharmaceutical Services, up from $65.1 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $68.6 million in Q2 2012 to a low of $60.5 million in Q4 2010.
  • A 3-year average of $65.0 million and a median of $65.1 million in 2011 frame the typical range for Raw Materials.
  • Across the five-year window, Raw Materials gained 7.6% in 2011 and rose 4.41% in 2012, its largest moves.
  • West Pharmaceutical Services' Raw Materials stood at $60.5 million in 2010, then rose by 7.6% to $65.1 million in 2011, then rose by 5.38% to $68.6 million in 2012.
  • According to Business Quant data, Raw Materials over the past three periods registered $68.6 million, $65.1 million, and $64.9 million for Q2 2012, Q4 2011, and Q3 2011 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Repligen 6.39 Bn 5.41 Bn 108.28 Mn

Historic Data

Download Data 🔒
DateValue
Jun 30, 2012 68.60 Mn
Dec 31, 2011 65.10 Mn
Sep 30, 2011 64.90 Mn
Jun 30, 2011 65.70 Mn
Dec 31, 2010 60.50 Mn